{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T21:05:00Z","timestamp":1788123900735,"version":"build-2803163510"},"reference-count":90,"publisher":"Bentham Science Publishers Ltd.","issue":"30","funder":[{"DOI":"10.13039\/501100003593","name":"Brazilian National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["309648\/2019-0"],"award-info":[{"award-number":["309648\/2019-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Brazilian National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["431254\/2018-4"],"award-info":[{"award-number":["431254\/2018-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2021,12,22]]},"abstract":"<jats:sec><jats:title\/><jats:p>Respiratory viruses continue to afflict mankind. Among them, pathogens such as coronaviruses [including the current pandemic agent known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] and the one causing influenza A (IAV) are highly contagious and deadly. These can evade the immune system defenses while causing a hyperinflammatory response that can damage different tissues\/organs. Simultaneously targeting several immunomodulatory proteins is a plausible antiviral strategy since it could lead to the discovery of indirect-acting pan-antiviral (IAPA) agents for the treatment of diseases caused by respiratory viruses. In this context, computational approaches, which are an essential part of the modern drug discovery campaigns, could accelerate the identification of multi-target immunomodulators. This perspective discusses the usefulness of computational multi-target drug discovery for the virtual screening (drug repurposing) of IAPA agents capable of boosting the immune system through the activation of the toll-like receptor 7 (TLR7) and\/or the stimulator of interferon genes (STING) while inhibiting key inflammation-related proteins such as caspase-1 and tumor necrosis factor-alpha (TNF-&amp;#945;).<\/jats:p><\/jats:sec>","DOI":"10.2174\/1568026621666211012110819","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T23:09:19Z","timestamp":1634339359000},"page":"2687-2693","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Indirect-Acting Pan-Antivirals vs. Respiratory Viruses: A Fresh Perspective on Computational Multi-Target Drug Discovery"],"prefix":"10.2174","volume":"21","author":[{"given":"Valeria V.","family":"Kleandrova","sequence":"first","affiliation":[{"name":"Laboratory of Fundamental and Applied Research of Quality and Technology of Food Production, Moscow State University of Food Production, Volokolamskoe Shosse 11, 125080, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus T.","family":"Scotti","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Para\u00edba, 58051-900, Jo\u00e3o Pessoa, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Speck-Planche","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Para\u00edba, 58051-900, Jo\u00e3o Pessoa, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","volume":"362","author":"Zhong N.S.","year":"2003","unstructured":"Zhong N.S.; Zheng B.J.; Li Y.M.; Poon ; Xie Z.H.; Chan K.H.; Li P.H.; Tan S.Y.; Chang Q.; Xie J.P.; Liu X.Q.; Xu J.; Li D.X.; Yuen K.Y.; Peiris ; Guan Y.; Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003. Lancet 2003,362(9393),1353-1358","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1046\/j.1440-1843.2003.00518.x","volume":"8","author":"Chan-Yeung M.","year":"2003","unstructured":"Chan-Yeung M.; Xu R.H.; SARS: epidemiology. Respirology 2003,8(Suppl.),S9-S14","journal-title":"Respirology"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1473-3099(15)70128-3","volume":"15","author":"Kayali G.","year":"2015","unstructured":"Kayali G.; Peiris M.; A more detailed picture of the epidemiology of Middle East respiratory syndrome coronavirus. Lancet Infect Dis 2015,15(5),495-497","journal-title":"Lancet Infect Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S1473-3099(14)70821-7","volume":"14","author":"Dunning J.","year":"2014","unstructured":"Dunning J.; Baillie J.K.; Cao B.; Hayden F.G.; Antiviral combinations for severe influenza. Lancet Infect Dis 2014,14(12),1259-1270","journal-title":"Lancet Infect Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"Dong E.","year":"2020","unstructured":"Dong E.; Du H.; Gardner L.; An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020,20(5),533-534","journal-title":"Lancet Infect Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3390\/v13061171","volume":"13","author":"Chaqroun A.","year":"2021","unstructured":"Chaqroun A.; Hartard C.; Schvoerer E.; Anti-SARS-CoV-2 vaccines and monoclonal antibodies facing viral variants. Viruses 2021,13(6),1171","journal-title":"Viruses"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","volume":"596","author":"Planas D.","year":"2021","unstructured":"Planas D.; Veyer D.; Baidaliuk A.; Staropoli I.; Guivel-Benhassine F.; Rajah M.M.; Planchais C.; Porrot F.; Robillard N.; Puech J.; Prot M.; Gallais F.; Gantner P.; Velay A.; Le Guen J.; Kassis-Chikhani N.; Edriss D.; Belec L.; Seve A.; Courtellemont L.; P\u00e9r\u00e9 H.; Hocqueloux L.; Fafi-Kremer S.; Prazuck T.; Mouquet H.; Bruel T.; Simon-Lori\u00e8re E.; Rey F.A.; Schwartz O.; Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature 2021,596(7871),276-280","journal-title":"Nature"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2108891","volume":"385","author":"Lopez Bernal J.","year":"2021","unstructured":"Lopez Bernal J.; Andrews N.; Gower C.; Gallagher E.; Simmons R.; Thelwall S.; Stowe J.; Tessier E.; Groves N.; Dabrera G.; Myers R.; Campbell C.N.J.; Amirthalingam G.; Edmunds M.; Zambon M.; Brown K.E.; Hopkins S.; Chand M.; Ramsay M.; Effectiveness of covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med 2021,385(7),585-594","journal-title":"N Engl J Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e01381","DOI":"10.1128\/JVI.01381-18","volume":"93","author":"Kleine-Weber H.","year":"2019","unstructured":"Kleine-Weber H.; Elzayat M.T.; Wang L.; Graham B.S.; M\u00fcller M.A.; Drosten C.; P\u00f6hlmann S.; Hoffmann M.; Mutations in the spike protein of middle east respiratory syndrome coronavirus transmitted in korea increase resistance to antibody-mediated neutralization. J Virol 2019,93(2),e01381-e18","journal-title":"J Virol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fimmu.2019.00132","volume":"10","author":"Nieto A.","year":"2019","unstructured":"Nieto A.; Vasilijevic J.; Santos N.B.; Zamarre\u00f1o N.; L\u00f3pez P.; Amorim M.J.; Falcon A.; Mutation S110L of H1N1 influenza virus hemagglutinin: A potent determinant of attenuation in the mouse model. Front Immunol 2019,10,132","journal-title":"Front Immunol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1007\/s00705-018-3962-z","volume":"163","author":"Al Khatib H.A.","year":"2018","unstructured":"Al Khatib H.A.; Al Thani A.A.; Yassine H.M.; Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017. Arch Virol 2018,163(11),3035-3049","journal-title":"Arch Virol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e18956","DOI":"10.1371\/journal.pone.0018956","volume":"6","author":"Morlighem J.E.","year":"2011","unstructured":"Morlighem J.E.; Aoki S.; Kishima M.; Hanami M.; Ogawa C.; Jalloh A.; Takahashi Y.; Kawai Y.; Saga S.; Hayashi E.; Ban T.; Izumi S.; Wada A.; Mano M.; Fukunaga M.; Kijima Y.; Shiomi M.; Inoue K.; Hata T.; Koretsune Y.; Kudo K.; Himeno Y.; Hirai A.; Takahashi K.; Sakai-Tagawa Y.; Iwatsuki-Horimoto K.; Kawaoka Y.; Hayashizaki Y.; Ishikawa T.; Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic. PLoS One 2011,6(4),e18956","journal-title":"PLoS One"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"e00216","DOI":"10.1128\/JVI.00216-20","volume":"94","author":"Chang P.","year":"2020","unstructured":"Chang P.; Sealy J.E.; Sadeyen J.R.; Bhat S.; Lukosaityte D.; Sun Y.; Iqbal M.; Immune escape adaptive mutations in the H7N9 avian influenza hemagglutinin protein increase virus replication fitness and decrease pandemic potential. J Virol 2020,94(19),e00216-e00220","journal-title":"J Virol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e00483","DOI":"10.1128\/AAC.00483-20","volume":"64","author":"Li H.","year":"2020","unstructured":"Li H.; Zhou Y.; Zhang M.; Wang H.; Zhao Q.; Liu J.; Updated approaches against SARS-CoV-2. Antimicrob Agents Chemother 2020,64(6),e00483-e20","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1007\/s00018-014-1615-2","volume":"71","author":"Loregian A.","year":"2014","unstructured":"Loregian A.; Mercorelli B.; Nannetti G.; Compagnin C.; Pal\u00f9 G.; Antiviral strategies against influenza virus: Towards new therapeutic approaches. Cell Mol Life Sci 2014,71(19),3659-3683","journal-title":"Cell Mol Life Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.antiviral.2012.09.013","volume":"96","author":"Lee S.M.","year":"2012","unstructured":"Lee S.M.; Yen H.L.; Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection. Antiviral Res 2012,96(3),391-404","journal-title":"Antiviral Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"eabg4535","DOI":"10.1126\/scitranslmed.abg4535","volume":"13","author":"Guthmiller J.J.","year":"2021","unstructured":"Guthmiller J.J.; Han J.; Li L.; Freyn A.W.; Liu S.T.H.; Stovicek O.; Stamper C.T.; Dugan H.L.; Tepora M.E.; Utset H.A.; Bitar D.J.; Hamel N.J.; Changrob S.; Zheng N.Y.; Huang M.; Krammer F.; Nachbagauer R.; Palese P.; Ward A.B.; Wilson P.C.; First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes. Sci Transl Med 2021,13(596),eabg4535","journal-title":"Sci Transl Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"108036","DOI":"10.1016\/j.intimp.2021.108036","volume":"99","author":"Batista C.M.","year":"2021","unstructured":"Batista C.M.; Foti L.; Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives. Int Immunopharmacol 2021,99,108036","journal-title":"Int Immunopharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3389\/fmicb.2019.01781","volume":"10","author":"Yong C.Y.","year":"2019","unstructured":"Yong C.Y.; Ong H.K.; Yeap S.K.; Ho K.L.; Tan W.S.; Recent advances in the vaccine development against middle east respiratory syndrome-coronavirus. Front Microbiol 2019,10,1781","journal-title":"Front Microbiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1038\/s41467-021-23328-0","volume":"12","author":"Bakowski M.A.","year":"2021","unstructured":"Bakowski M.A.; Beutler N.; Wolff K.C.; Kirkpatrick M.G.; Chen E.; Nguyen T.H.; Riva L.; Shaabani N.; Parren M.; Ricketts J.; Gupta A.K.; Pan K.; Kuo P.; Fuller M.; Garcia E.; Teijaro J.R.; Yang L.; Sahoo D.; Chi V.; Huang E.; Vargas N.; Roberts A.J.; Das S.; Ghosh P.; Woods A.K.; Joseph S.B.; Hull M.V.; Schultz P.G.; Burton D.R.; Chatterjee A.K.; McNamara C.W.; Rogers T.F.; Drug repurposing screens identify chemical entities for the development of COVID-19 interventions. Nat Commun 2021,12(1),3309","journal-title":"Nat Commun"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.1128\/JVI.00898-16","volume":"90","author":"Weisshaar M.","year":"2016","unstructured":"Weisshaar M.; Cox R.; Morehouse Z.; Kumar Kyasa S.; Yan D.; Oberacker P.; Mao S.; Golden J.E.; Lowen A.C.; Natchus M.G.; Plemper R.K.; Identification and characterization of influenza virus entry inhibitors through dual myxovirus high-throughput screening. J Virol 2016,90(16),7368-7387","journal-title":"J Virol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1177\/1087057111435236","volume":"17","author":"Dai J.","year":"2012","unstructured":"Dai J.; Wang G.; Li W.; Zhang L.; Yang J.; Zhao X.; Chen X.; Xu Y.; Li K.; High-throughput screening for anti-influenza A virus drugs and study of the mechanism of procyanidin on influenza A virus-induced autophagy. J Biomol Screen 2012,17(5),605-617","journal-title":"J Biomol Screen"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.chembiol.2004.08.011","volume":"11","author":"Blanchard J.E.","year":"2004","unstructured":"Blanchard J.E.; Elowe N.H.; Huitema C.; Fortin P.D.; Cechetto J.D.; Eltis L.D.; Brown E.D.; High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. Chem Biol 2004,11(10),1445-1453","journal-title":"Chem Biol"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-021-00836-9","author":"Zhao Y.","year":"2021","unstructured":"Zhao Y.; Du X.; Duan Y.; Pan X.; Sun Y.; You T.; Han L.; Jin Z.; Shang W.; Yu J.; Guo H.; Liu Q.; Wu Y.; Peng C.; Wang J.; Zhu C.; Yang X.; Yang K.; Lei Y.; Guddat L.W.; Xu W.; Xiao G.; Sun L.; Zhang L.; Rao Z.; Yang H.; High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors. Protein Cell 2021","journal-title":"Protein Cell"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ijantimicag.2018.05.003","volume":"52","author":"Kim J.Y.","year":"2018","unstructured":"Kim J.Y.; Kim Y.I.; Park S.J.; Kim I.K.; Choi Y.K.; Kim S.H.; Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein. Int J Antimicrob Agents 2018,52(5),730-732","journal-title":"Int J Antimicrob Agents"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e00023","DOI":"10.1128\/JVI.00023-19","volume":"93","author":"Shen L.","year":"2019","unstructured":"Shen L.; Niu J.; Wang C.; Huang B.; Wang W.; Zhu N.; Deng Y.; Wang H.; Ye F.; Cen S.; Tan W.; High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses. J Virol 2019,93(12),e00023-e19","journal-title":"J Virol"},{"key":"ref=27","author":"Bunin B.A.","year":"2007","unstructured":"Bunin B.A.; Bajorath J.; Siesel B.; Morales G.; Chemoinformatics: Theory, Practice and Products 2007","journal-title":"Chemoinformatics: Theory, Practice and Products"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1002\/9783527618279","author":"Gasteiger J.","year":"2003","unstructured":"Gasteiger J.; Handbook of Chemoinformatics 2003","journal-title":"Handbook of Chemoinformatics"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1002\/3527603743","author":"Oprea T.","year":"2005","unstructured":"Oprea T.; Chemoinformatics in Drug Discovery 2005","journal-title":"Chemoinformatics in Drug Discovery"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"9121","DOI":"10.1039\/D0CS01065K","volume":"50","author":"Muratov E.N.","year":"2021","unstructured":"Muratov E.N.; Amaro R.; Andrade C.H.; Brown N.; Ekins S.; Fourches D.; Isayev O.; Kozakov D.; Medina-Franco J.L.; Merz K.M.; Oprea T.I.; Poroikov V.; Schneider G.; Todd M.H.; Varnek A.; Winkler D.A.; Zakharov A.V.; Cherkasov A.; Tropsha A.; A critical overview of computational approaches employed for COVID-19 drug discovery. Chem Soc Rev 2021,50(16),9121-9151","journal-title":"Chem Soc Rev"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s43588-020-00007-6","volume":"1","author":"Galindez G.","year":"2021","unstructured":"Galindez G.; Matschinske J.; Rose T.D.; Sadegh S.; Salgado-Albarr\u00e1n M.; Sp\u00e4th J.; Baumbach J.; Pauling J.K.; Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies. Nat Comput Sci 2021,1,33-41","journal-title":"Nat Comput Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"104490","DOI":"10.1016\/j.bioorg.2020.104490","volume":"106","author":"Mohamed K.","year":"2021","unstructured":"Mohamed K.; Yazdanpanah N.; Saghazadeh A.; Rezaei N.; Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review. Bioorg Chem 2021,106,104490","journal-title":"Bioorg Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/v12040404","volume":"12","author":"Cava C.","year":"2020","unstructured":"Cava C.; Bertoli G.; Castiglioni I.; In silico discovery of candidate drugs against covid-19. Viruses 2020,12(4),404","journal-title":"Viruses"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/bib\/bbaa288","volume":"22","author":"Dotolo S.","year":"2021","unstructured":"Dotolo S.; Marabotti A.; Facchiano A.; Tagliaferri R.; A review on drug repurposing applicable to COVID-19. Brief Bioinform 2021,22(2),726-741","journal-title":"Brief Bioinform"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e0251913","DOI":"10.1371\/journal.pone.0251913","volume":"16","author":"v K P.","year":"2021","unstructured":"v K P.; Rath S.P.; Abraham P.; Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV. PLoS One 2021,16(5),e0251913-e0251913","journal-title":"PLoS One"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"15431","DOI":"10.1038\/s41598-021-92176-1","volume":"11","author":"Mahmud S.","year":"2021","unstructured":"Mahmud S.; Rafi M.O.; Paul G.K.; Promi M.M.; Shimu M.S.S.; Biswas S.; Emran T.B.; Dhama K.; Alyami S.A.; Moni M.A.; Saleh M.A.; Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach. Sci Rep 2021,11(1),15431","journal-title":"Sci Rep"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jpha.2020.08.012","volume":"10","author":"Alamri M.A.","year":"2020","unstructured":"Alamri M.A.; Tahir Ul Qamar M.; Mirza M.U.; Alqahtani S.M.; Froeyen M.; Chen L.L.; Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches. J Pharm Anal 2020,10(6),546-559","journal-title":"J Pharm Anal"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/vaccines7020045","volume":"7","author":"Qiu X.","year":"2019","unstructured":"Qiu X.; Duvvuri V.R.; Bahl J.; Computational approaches and challenges to developing universal influenza vaccines. Vaccines (Basel) 2019,7(2),45","journal-title":"Vaccines (Basel)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e0239112","DOI":"10.1371\/journal.pone.0239112","volume":"15","author":"Do P.C.","year":"2020","unstructured":"Do P.C.; Nguyen T.H.; Vo U.H.M.; Le L.; iBRAB: In silico based-designed broad-spectrum Fab against H1N1 influenza A virus. PLoS One 2020,15(12),e0239112","journal-title":"PLoS One"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"104677","DOI":"10.1016\/j.compbiomed.2021.104677","volume":"136","author":"Rajput A.","year":"2021","unstructured":"Rajput A.; Thakur A.; Rastogi A.; Choudhury S.; Kumar M.; Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis. Comput Biol Med 2021,136,104677","journal-title":"Comput Biol Med"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/ph14040371","volume":"14","author":"Ye J.","year":"2021","unstructured":"Ye J.; Lin L.; Xu J.; Chan P.K-S.; Yang X.; Ma C.; Design, synthesis, biological evaluation and in silico studies of pyrazole-based NH-Acyl oseltamivir analogues as potent neuraminidase inhibitors. Pharmaceuticals (Basel) 2021,14(4),371","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4155\/fmc-2020-0134","volume":"13","author":"V Kleandrova V.","year":"2021","unstructured":"V Kleandrova V.; Speck-Planche A.; The urgent need for pan-antiviral agents: From multitarget discovery to multiscale design. Future Med Chem 2021,13(1),5-8","journal-title":"Future Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/QCO.0000000000000447","volume":"31","author":"McArdle A.J.","year":"2018","unstructured":"McArdle A.J.; Turkova A.; Cunnington A.J.; When do co-infections matter? Curr Opin Infect Dis 2018,31(3),209-215","journal-title":"Curr Opin Infect Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jinf.2011.06.005","volume":"63","author":"Griffiths E.C.","year":"2011","unstructured":"Griffiths E.C.; Pedersen A.B.; Fenton A.; Petchey O.L.; The nature and consequences of coinfection in humans. J Infect 2011,63(3),200-206","journal-title":"J Infect"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jtbi.2008.06.004","volume":"254","author":"Merler S.","year":"2008","unstructured":"Merler S.; Poletti P.; Ajelli M.; Caprile B.; Manfredi P.; Coinfection can trigger multiple pandemic waves. J Theor Biol 2008,254(2),499-507","journal-title":"J Theor Biol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41422-021-00473-1","volume":"31","author":"Bai L.","year":"2021","unstructured":"Bai L.; Zhao Y.; Dong J.; Liang S.; Guo M.; Liu X.; Wang X.; Huang Z.; Sun X.; Zhang Z.; Dong L.; Liu Q.; Zheng Y.; Niu D.; Xiang M.; Song K.; Ye J.; Zheng W.; Tang Z.; Tang M.; Zhou Y.; Shen C.; Dai M.; Zhou L.; Chen Y.; Yan H.; Lan K.; Xu K.; Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res 2021,31(4),395-403","journal-title":"Cell Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e0251170","DOI":"10.1371\/journal.pone.0251170","volume":"16","author":"Musuuza J.S.","year":"2021","unstructured":"Musuuza J.S.; Watson L.; Parmasad V.; Putman-Buehler N.; Christensen L.; Safdar N.; Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS One 2021,16(5),e0251170","journal-title":"PLoS One"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jinf.2011.04.004","volume":"63","author":"Esper F.P.","year":"2011","unstructured":"Esper F.P.; Spahlinger T.; Zhou L.; Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease. J Infect 2011,63(4),260-266","journal-title":"J Infect"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1039\/D0CS01118E","volume":"50","author":"Adamson C.S.","year":"2021","unstructured":"Adamson C.S.; Chibale K.; Goss R.J.M.; Jaspars M.; Newman D.J.; Dorrington R.A.; Antiviral drug discovery: Preparing for the next pandemic. Chem Soc Rev 2021,50(6),3647-3655","journal-title":"Chem Soc Rev"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3389\/fmicb.2020.01756","volume":"11","author":"Bello-Onaghise G.","year":"2020","unstructured":"Bello-Onaghise G.; Wang G.; Han X.; Nsabimana E.; Cui W.; Yu F.; Zhang Y.; Wang L.; Li Z.; Cai X.; Li Y.; Antiviral strategies of chinese herbal medicine against PRRSV infection. Front Microbiol 2020,11,1756","journal-title":"Front Microbiol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"e1002468","DOI":"10.1371\/journal.ppat.1002468","volume":"8","author":"Olmstead A.D.","year":"2012","unstructured":"Olmstead A.D.; Knecht W.; Lazarov I.; Dixit S.B.; Jean F.; Human subtilase SKI-1\/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents. PLoS Pathog 2012,8(1),e1002468-e1002468","journal-title":"PLoS Pathog"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/jmv.26826","volume":"93","author":"Khanmohammadi S.","year":"2021","unstructured":"Khanmohammadi S.; Rezaei N.; Role of Toll-like receptors in the pathogenesis of COVID-19. J Med Virol 2021,93(5),2735-2739","journal-title":"J Med Virol"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/bs.aivir.2016.08.006","volume":"Vol. 96","author":"Kindler E.","year":"2016","unstructured":"Kindler E.; Thiel V.; Weber F.; Chapter Seven - Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response. Advances in Virus Research 2016,Vol. 96,219-243","journal-title":"Advances in Virus Research"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"10988","DOI":"10.1128\/JVI.01064-12","volume":"86","author":"Jeisy-Scott V.","year":"2012","unstructured":"Jeisy-Scott V.; Kim J.H.; Davis W.G.; Cao W.; Katz J.M.; Sambhara S.; TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice. J Virol 2012,86(20),10988-10998","journal-title":"J Virol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s11033-011-0846-7","volume":"39","author":"Liu Y.","year":"2012","unstructured":"Liu Y.; Chen H.; Sun Y.; Chen F.; Antiviral role of Toll-like receptors and cytokines against the new 2009 H1N1 virus infection. Mol Biol Rep 2012,39(2),1163-1172","journal-title":"Mol Biol Rep"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"eabi9002","DOI":"10.1126\/sciimmunol.abi9002","volume":"6","author":"Humphries F.","year":"2021","unstructured":"Humphries F.; Shmuel-Galia L.; Jiang Z.; Wilson R.; Landis P.; Ng S-L.; Parsi K-M.; Maehr R.; Cruz J.; Morales-Ramos A.; Ramanjulu J.M.; Bertin J.; Pesiridis G.S.; Fitzgerald K.A.; A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci Immunol 2021,6(59),eabi9002","journal-title":"Sci Immunol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/356768a0","volume":"356","author":"Thornberry N.A.","year":"1992","unstructured":"Thornberry N.A.; Bull H.G.; Calaycay J.R.; Chapman K.T.; Howard A.D.; Kostura M.J.; Miller D.K.; Molineaux S.M.; Weidner J.R.; Aunins J.; Elliston K.O.; Ayala J.M.; Casano F.J.; Chin J.; Ding G.J.F.; Egger L.A.; Gaffney E.P.; Limjuco G.; Palyha O.C.; Raju S.M.; Rolando A.M.; Salley J.P.; Yamin T-T.; Lee T.D.; Shively J.E.; MacCross M.; Mumford R.A.; Schmidt J.A.; Tocci M.J.; A novel heterodimeric cysteine protease is required for interleukin-1 \u03b2 processing in monocytes. Nature 1992,356(6372),768-774","journal-title":"Nature"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1373520","volume":"256","author":"Cerretti D.P.","year":"1992","unstructured":"Cerretti D.P.; Kozlosky C.J.; Mosley B.; Nelson N.; Van Ness K.; Greenstreet T.A.; March C.J.; Kronheim S.R.; Druck T.; Cannizzaro L.A.; Molecular cloning of the interleukin-1 beta converting enzyme. Science 1992,256(5053),97-100","journal-title":"Science"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature02664","volume":"430","author":"Mariathasan S.","year":"2004","unstructured":"Mariathasan S.; Newton K.; Monack D.M.; Vucic D.; French D.M.; Lee W.P.; Roose-Girma M.; Erickson S.; Dixit V.M.; Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004,430(6996),213-218","journal-title":"Nature"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41586-021-03478-3","volume":"593","author":"Xia S.","year":"2021","unstructured":"Xia S.; Zhang Z.; Magupalli V.G.; Pablo J.L.; Dong Y.; Vora S.M.; Wang L.; Fu T.M.; Jacobson M.P.; Greka A.; Lieberman J.; Ruan J.; Wu H.; Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature 2021,593(7860),607-611","journal-title":"Nature"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","volume":"128","author":"Wang W.","year":"2007","unstructured":"Wang W.; Ye L.; Ye L.; Li B.; Gao B.; Zeng Y.; Kong L.; Fang X.; Zheng H.; Wu Z.; She Y.; Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway. Virus Res 2007,128(1-2),1-8","journal-title":"Virus Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","volume":"104","author":"Mahallawi W.H.","year":"2018","unstructured":"Mahallawi W.H.; Khabour O.F.; Zhang Q.; Makhdoum H.M.; Suliman B.A.; MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine 2018,104,8-13","journal-title":"Cytokine"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"R301","DOI":"10.1186\/cc13171","volume":"17","author":"Shi X.","year":"2013","unstructured":"Shi X.; Zhou W.; Huang H.; Zhu H.; Zhou P.; Zhu H.; Ju D.; Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice. Crit Care 2013,17(6),R301","journal-title":"Crit Care"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/jcp.25385","volume":"231","author":"Furuoka M.","year":"2016","unstructured":"Furuoka M.; Ozaki K.; Sadatomi D.; Mamiya S.; Yonezawa T.; Tanimura S.; Takeda K.; TNF-\u03b1 induces caspase-1 activation independently of simultaneously induced NLRP3 in 3T3-L1 cells. J Cell Physiol 2016,231(12),2761-2767","journal-title":"J Cell Physiol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"7566","DOI":"10.1074\/jbc.273.13.7566","volume":"273","author":"De Cesaris P.","year":"1998","unstructured":"De Cesaris P.; Starace D.; Riccioli A.; Padula F.; Filippini A.; Ziparo E.; Tumor necrosis factor-alpha induces interleukin-6 production and integrin ligand expression by distinct transduction pathways. J Biol Chem 1998,273(13),7566-7571","journal-title":"J Biol Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1021\/acs.molpharmaceut.9b00538","volume":"16","author":"V\u00e1squez-Dom\u00ednguez E.","year":"2019","unstructured":"V\u00e1squez-Dom\u00ednguez E.; Armijos-Jaramillo V.D.; Tejera E.; Gonz\u00e1lez-D\u00edaz H.; Multioutput perturbation-theory machine learning (PTML) model of chembl data for antiretroviral compounds. Mol Pharm 2019,16(10),4200-4212","journal-title":"Mol Pharm"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1517\/17460441.2015.1006195","volume":"10","author":"Speck-Planche A.","year":"2015","unstructured":"Speck-Planche A.; Cordeiro M.N.D.S.; Multitasking models for quantitative structure-biological effect relationships: Current status and future perspectives to speed up drug discovery. Expert Opin Drug Discov 2015,10(3),245-256","journal-title":"Expert Opin Drug Discov"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"Gaulton A.","year":"2012","unstructured":"Gaulton A.; Bellis L.J.; Bento A.P.; Chambers J.; Davies M.; Hersey A.; Light Y.; McGlinchey S.; Michalovich D.; Al-Lazikani B.; Overington J.P.; ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Res 2012,40(Database issue),D1100-D1107","journal-title":"Nucleic Acids Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"Mendez D.","year":"2019","unstructured":"Mendez D.; Gaulton A.; Bento A.P.; Chambers J.; De Veij M.; F\u00e9lix E.; Magari\u00f1os M.P.; Mosquera J.F.; Mutowo P.; Nowotka M.; Gordillo-Mara\u00f1\u00f3n M.; Hunter F.; Junco L.; Mugumbate G.; Rodriguez-Lopez M.; Atkinson F.; Bosc N.; Radoux C.J.; Segura-Cabrera A.; Hersey A.; Leach A.R.; ChEMBL: Towards direct deposition of bioassay data. Nucleic Acids Res 2019,47(D1),D930-D940","journal-title":"Nucleic Acids Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1021\/ci200260t","volume":"51","author":"Mok N.Y.","year":"2011","unstructured":"Mok N.Y.; Brenk R.; Mining the ChEMBL database: An efficient chemoinformatics workflow for assembling an ion channel-focused screening library. J Chem Inf Model 2011,51(10),2449-2454","journal-title":"J Chem Inf Model"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1021\/acscombsci.8b00090","volume":"20","author":"Bediaga H.","year":"2018","unstructured":"Bediaga H.; Arrasate S.; Gonz\u00e1lez-D\u00edaz H.; PTML combinatorial model of ChEMBL compounds assays for multiple types of cancer. ACS Comb Sci 2018,20(11),621-632","journal-title":"ACS Comb Sci"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.1002\/9783527613106","author":"Todeschini R.","year":"2000","unstructured":"Todeschini R.; Consonni V.; Handbook of Molecular Descriptors 2000","journal-title":"Handbook of Molecular Descriptors"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejps.2009.10.007","volume":"39","author":"Castillo-Garit J.A.","year":"2010","unstructured":"Castillo-Garit J.A.; Vega M.C.; Rolon M.; Marrero-Ponce Y.; Kouznetsov V.V.; Torres D.F.; G\u00f3mez-Barrio A.; Bello A.A.; Montero A.; Torrens F.; P\u00e9rez-Gim\u00e9nez F.; Computational discovery of novel trypanosomicidal drug-like chemicals by using bond-based non-stochastic and stochastic quadratic maps and linear discriminant analysis. Eur J Pharm Sci 2010,39(1-3),30-36","journal-title":"Eur J Pharm Sci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1747-0285.2010.01032.x","volume":"76","author":"Casa\u00f1ola-Martin G.M.","year":"2010","unstructured":"Casa\u00f1ola-Martin G.M.; Marrero-Ponce Y.; Khan M.T.; Khan S.B.; Torrens F.; P\u00e9rez-Jim\u00e9nez F.; Rescigno A.; Abad C.; Bond-based 2D quadratic fingerprints in QSAR studies: Virtual and in vitro tyrosinase inhibitory activity elucidation. Chem Biol Drug Des 2010,76(6),538-545","journal-title":"Chem Biol Drug Des"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.bmc.2010.01.068","volume":"18","author":"Prado-Prado F.J.","year":"2010","unstructured":"Prado-Prado F.J.; Garc\u00eda-Mera X.; Gonz\u00e1lez-D\u00edaz H.; Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorg Med Chem 2010,18(6),2225-2231","journal-title":"Bioorg Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1021\/ci000170v","volume":"41","author":"Estrada E.","year":"2001","unstructured":"Estrada E.; Molina E.; Perdomo-L\u00f3pez I.; Can 3D structural parameters be predicted from 2D (topological) molecular descriptors? J Chem Inf Comput Sci 2001,41(4),1015-1021","journal-title":"J Chem Inf Comput Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"9085","DOI":"10.1021\/jp026238m","volume":"106","author":"Estrada E.","year":"2002","unstructured":"Estrada E.; Physicochemical interpretation of molecular connectivity indices. J Phys Chem A 2002,106,9085-9091","journal-title":"J Phys Chem A"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/10629360008033229","volume":"11","author":"Estrada E.","year":"2000","unstructured":"Estrada E.; On the topological sub-structural molecular design (TOSS-MODE) in QSPR\/QSAR and drug design research. SAR QSAR Environ Res 2000,11(1),55-73","journal-title":"SAR QSAR Environ Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1021\/jm991172d","volume":"43","author":"Estrada E.","year":"2000","unstructured":"Estrada E.; Uriarte E.; Montero A.; Teijeira M.; Santana L.; De Clercq E.; A novel approach for the virtual screening and rational design of anticancer compounds. J Med Chem 2000,43(10),1975-1985","journal-title":"J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00044-017-1936-4","volume":"26","author":"Speck-Planche A.","year":"2017","unstructured":"Speck-Planche A.; Cordeiro M.N.D.S.; De novo computational design of compounds virtually displaying potent antibacterial activity and desirable in vitro ADMET profiles. Med Chem Res 2017,26,2345-2356","journal-title":"Med Chem Res"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/jcc.21374","volume":"31","author":"Planche A.S.","year":"2010","unstructured":"Planche A.S.; Scotti M.T.; Emerenciano Vde.P.; L\u00f3pez A.G.; P\u00e9rez E.M.; Uriarte E.; Designing novel antitrypanosomal agents from a mixed graph-theoretical substructural approach. J Comput Chem 2010,31(4),882-894","journal-title":"J Comput Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1039\/D0NR07588D","volume":"13","author":"Ortega-Tenezaca B.","year":"2021","unstructured":"Ortega-Tenezaca B.; Gonz\u00e1lez-D\u00edaz H.; IFPTML mapping of nanoparticle antibacterial activity vs. pathogen metabolic networks. Nanoscale 2021,13(2),1318-1330","journal-title":"Nanoscale"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1021\/acs.jcim.5b00630","volume":"56","author":"Speck-Planche A.","year":"2016","unstructured":"Speck-Planche A.; Kleandrova V.V.; Ruso J.M.; Cordeiro M.N.D.S.; First multitarget chemo-bioinformatic model to enable the discovery of antibacterial peptides against multiple Gram-positive pathogens. J Chem Inf Model 2016,56(3),588-598","journal-title":"J Chem Inf Model"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1021\/acscombsci.7b00039","volume":"19","author":"Speck-Planche A.","year":"2017","unstructured":"Speck-Planche A.; Dias Soeiro Cordeiro M.N.; Speeding up early drug discovery in antiviral research: A fragment-based in silico approach for the design of virtual anti-hepatitis C leads. ACS Comb Sci 2017,19(8),501-512","journal-title":"ACS Comb Sci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1021\/acschemneuro.0c00687","volume":"12","author":"Sampaio-Dias I.E.","year":"2021","unstructured":"Sampaio-Dias I.E.; Rodr\u00edguez-Borges J.E.; Y\u00e1\u00f1ez-P\u00e9rez V.; Arrasate S.; Llorente J.; Brea J.M.; Bediaga H.; Vi\u00f1a D.; Loza M.I.; Caama\u00f1o O.; Garc\u00eda-Mera X.; Gonz\u00e1lez-D\u00edaz H.; Synthesis, pharmacological, and biological evaluation of 2-furoyl-based MIF-1 peptidomimetics and the development of a general-purpose model for allosteric modulators (ALLOPTML). ACS Chem Neurosci 2021,12(1),203-215","journal-title":"ACS Chem Neurosci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1021\/acs.molpharmaceut.0c00308","volume":"17","author":"Santana R.","year":"2020","unstructured":"Santana R.; Zuluaga R.; Ga\u00f1\u00e1n P.; Arrasate S.; Onieva E.; Montemore M.M.; Gonz\u00e1lez-D\u00edaz H.; PTML model for selection of nanoparticles, anticancer drugs, and vitamins in the design of drug-vitamin nanoparticle release systems for cancer cotherapy. Mol Pharm 2020,17(7),2612-2627","journal-title":"Mol Pharm"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1021\/acschemneuro.9b00302","volume":"10","author":"Diez-Alarcia R.","year":"2019","unstructured":"Diez-Alarcia R.; Y\u00e1\u00f1ez-P\u00e9rez V.; Muneta-Arrate I.; Arrasate S.; Lete E.; Meana J.J.; Gonz\u00e1lez-D\u00edaz H.; Big data challenges targeting proteins in GPCR signaling pathways; combining PTML-ChEMBL models and [S]GTP\u03b3S binding assays. ACS Chem Neurosci 2019,10(11),4476-4491","journal-title":"ACS Chem Neurosci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2174\/1568026620666200607190951","volume":"20","author":"Kleandrova V.V.","year":"2020","unstructured":"Kleandrova V.V.; Speck-Planche A.; PTML modeling for Alzheimer\u2019s Disease: Design and prediction of virtual multi-target inhibitors of GSK3B, HDAC1, and HDAC6. Curr Top Med Chem 2020,20(19),1661-1676","journal-title":"Curr Top Med Chem"},{"key":"ref=89","author":"Box G.","year":"1970","unstructured":"Box G.; Jenkins G.; Time series analysis: Forecasting and control 1970","journal-title":"Time series analysis: Forecasting and control"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/antibiotics10081005","volume":"10","author":"Kleandrova V.V.","year":"2021","unstructured":"Kleandrova V.V.; Scotti M.T.; Speck-Planche A.; Computational drug repurposing for antituberculosis therapy: Discovery of multi- strain inhibitors. Antibiotics (Basel) 2021,10(8),1005","journal-title":"Antibiotics (Basel)"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/197183","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197183\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/197183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T07:37:11Z","timestamp":1699688231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197183\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":90,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2021,12,22]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026621666211012110819","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}